TickerFacts.

Veru Inc. (VERU): Cash & Equivalents

Annual figures by period end, from SEC filings.

$15.79M
As of 2025-09-30
$23.88M
As of 2026-06-30
+14.4%
10-year compound annual growth
$24.92M2009-09-30: $2.81M2010-09-30: $2.92M2011-09-30: $4.25M2012-09-30: $5.30M2013-09-30: $8.92M2014-09-30: $5.80M2015-09-30: $4.11M2023-09-30: $9.63M2024-09-30: $24.92M2025-09-30: $15.79M$15.79M
2009-09-30 Cash & Equivalents (USD) 2025-09-30
Period endedCash & EquivalentsChange YoYSource filing
2025-09-30$15.79M-36.6%2025-12-17, Balance as of period end
2024-09-30$24.92M+158.9%2025-12-17, Balance as of period end
2023-09-30$9.63Mn/a2024-12-16, Balance as of period end
No annual figure between 2015-09-30 and 2023-09-30.
2015-09-30$4.11M-29.2%2015-12-02, Balance as of period end
2014-09-30$5.80M-35.0%2015-12-02, Balance as of period end
2013-09-30$8.92M+68.5%2015-12-02, Balance as of period end
2012-09-30$5.30M+24.5%2014-12-02, Balance as of period end
2011-09-30$4.25M+45.7%2013-12-03, Balance as of period end
2010-09-30$2.92M+3.9%2012-12-04, Balance as of period end
2009-09-30$2.81Mn/a2011-12-02, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Veru Inc. (VERU)2025-09-30$15.79M-36.6%
Sol-Gel Technologies Ltd. (SLGL)2025-12-31$11.03M-43.4%
Talphera, Inc. (TLPH)2025-12-31$5.89M-33.5%
Yarrow Bioscience, Inc. (YARW)2025-12-31$24.03M+20.6%
PDS Biotechnology Corp (PDSB)2025-12-31$26.71M-35.9%
China Pharma Holdings, Inc. (CPHI)2025-12-31$345.1K-44.9%
Neuphoria Therapeutics Inc. (NEUP)2026-06-30$19.87M+39.8%
Biofrontera Inc. (BFRI)2025-12-31$6.39M+8.2%
Skye Bioscience, Inc. (SKYE)2025-12-31$5.88M-91.4%

Compare VERU, SLGL, TLPH, YARW side by side · Screen every company in Pharmaceutical Preparations ↗